These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22305512)

  • 21. Opioid plasma concentration during switching from morphine to methadone: preliminary data.
    Mercadante S; Bianchi M; Villari P; Ferrera P; Casuccio A; Fulfaro F; Gebbia V
    Support Care Cancer; 2003 May; 11(5):326-31. PubMed ID: 12690541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medicating "Margaret".
    Reid C
    J Clin Ethics; 2006; 17(4):340-3. PubMed ID: 17330727
    [No Abstract]   [Full Text] [Related]  

  • 23. Methadone in the treatment of pain and terminal delirum in advanced cancer patients.
    Moryl N; Kogan M; Comfort C; Obbens E
    Palliat Support Care; 2005 Dec; 3(4):311-7. PubMed ID: 17039986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid rotation from methadone: fraught with difficulties.
    Bhimji K
    J Pain Symptom Manage; 2005 Apr; 29(4):334-5. PubMed ID: 15857735
    [No Abstract]   [Full Text] [Related]  

  • 25. Prescribing methadone, a unique analgesic.
    Manfredi PL; Houde RW
    J Support Oncol; 2003; 1(3):216-20. PubMed ID: 15334878
    [No Abstract]   [Full Text] [Related]  

  • 26. Interpretation of opioid levels: comparison of levels during chronic pain therapy to levels from forensic autopsies.
    Jung BF; Reidenberg MM
    Clin Pharmacol Ther; 2005 Apr; 77(4):324-34. PubMed ID: 15903130
    [No Abstract]   [Full Text] [Related]  

  • 27. Methadone in cancer pain management: individualize dose and titrate to effect.
    Foley KM; Houde RW
    J Clin Oncol; 1998 Oct; 16(10):3213-5. PubMed ID: 9779693
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacoeconomics evaluation of morphine, MS contin and oxycodone in the treatment of cancer pain.
    Zhang WZ; Yu WJ; Zhao XL; He BX
    Asian Pac J Cancer Prev; 2014; 15(20):8797-800. PubMed ID: 25374210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Switching From High-Dose, Long-Term Opioids to Buprenorphine: A Case Series.
    Becker WC; Frank JW; Edens EL
    Ann Intern Med; 2020 Jul; 173(1):70-71. PubMed ID: 32252072
    [No Abstract]   [Full Text] [Related]  

  • 30. Fentanyl tolerance in the treatment of cancer pain: a case of successful opioid switching from fentanyl to oxycodone at a reduced equivalent dose.
    Sutou I; Nakatani T; Hashimoto T; Saito Y
    J Pain Palliat Care Pharmacother; 2015 Jun; 29(2):161-5. PubMed ID: 26095488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid switching from morphine to methadone in cancer patients with poor response to morphine.
    Mercadante S; Casuccio A; Calderone L
    J Clin Oncol; 1999 Oct; 17(10):3307-12. PubMed ID: 10506634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WITHDRAWN: Opioid switching to improve pain relief and drug tolerability.
    Quigley C
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD004847. PubMed ID: 24142865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-opioid therapy: changing the paradigm. Panel discussion.
    Nicholson BD
    Pain Med; 2012 Mar; 13 Suppl 1():S21-2. PubMed ID: 22420603
    [No Abstract]   [Full Text] [Related]  

  • 35. Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy.
    Davis MP; Varga J; Dickerson D; Walsh D; LeGrand SB; Lagman R
    Support Care Cancer; 2003 Feb; 11(2):84-92. PubMed ID: 12560936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Morphine and alternative opioids in cancer pain: the EAPC recommendations.
    Hanks GW; Conno F; Cherny N; Hanna M; Kalso E; McQuay HJ; Mercadante S; Meynadier J; Poulain P; Ripamonti C; Radbruch L; Casas JR; Sawe J; Twycross RG; Ventafridda V;
    Br J Cancer; 2001 Mar; 84(5):587-93. PubMed ID: 11237376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid selective antinociception following microinjection into the periaqueductal gray of the rat.
    Morgan MM; Reid RA; Stormann TM; Lautermilch NJ
    J Pain; 2014 Nov; 15(11):1102-1109. PubMed ID: 25106089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain.
    Moryl N; Santiago-Palma J; Kornick C; Derby S; Fischberg D; Payne R; Manfredi PL
    Pain; 2002 Apr; 96(3):325-328. PubMed ID: 11973005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methadone for cancer pain: a case report.
    Nixon AJ
    Am J Hosp Palliat Care; 2005; 22(5):337. PubMed ID: 16225353
    [No Abstract]   [Full Text] [Related]  

  • 40. Factors predicting requirement of high-dose transdermal fentanyl in opioid switching from oral morphine or oxycodone in patients with cancer pain.
    Kanbayashi Y; Hosokawa T; Okamoto K; Fujimoto S; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Miki T; Taniwaki M
    Clin J Pain; 2011 Oct; 27(8):664-7. PubMed ID: 21471811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.